Tchaikapharma High Quality Medicines reported a 19.61% increase in sales revenue for the first half of the year, reaching BGN 32.11 million. Net profit as of the end of June stood at BGN 4.78 million, up from BGN 2.81 million in the same period last year, according to the company’s financial report for the second quarter.

The bulk of the revenue came from oral solid medicines sales, which generated BGN 25.64 million.

Operating expenses, which are primarily related to the production and distribution of medicinal products, totaled BGN 27 million. The largest cost components were materials, external services, and employee remuneration.

Tchaikapharma is among the fastest-growing pharmaceutical companies in Bulgaria, specializing in the production of high-quality, affordable generic medicines. Its manufacturing facilities in Varna and Plovdiv currently produce over 160 medicinal products. To meet growing demand, the company expanded its workforce to 216 employees by the end of June, up from 207 in December.